This includes people with a personal or family history of medullary thyroid carcinoma, a rare form of thyroid cancer
When to Explore Alternative Compounded GLP-1 Options If you've maintained consistent technique, nutrition, and activity for 68 weeks without progress, exploring alternative medications becomes reasonable
Insurance coverage for semaglutide varies significantly depending on whether you're using it to manage diabetes or to lose weight
How your care works Dual-action GLP-1 + GIP receptor agonist Tirzepatide is the active ingredient in your prescription
Semaglutide is the most extensively studied GLP-1 receptor agonist a single, highly selective incretin-pathway agonist that has become the reference standard against which newer dual and triple agonists are measured
Fatigue: If you feel tired after your dose, consider taking it in the evening to avoid disrupting your day